Zdrowie i gospodarka · 24/06/2022
FDA Releases Draft Guidance on Preventing Cross-Contamination in Non-Penicillin Beta-Lactam Drugs
The FDA is releasing a draft guidance to help pharmaceutical manufacturers prevent cross-contamination in non-penicillin beta-lactam drugs, which could pose health risks to consumers.